Replies to post #21555 on The Rising Influence of Rising Affluence

[DewDiligence]

The world has changed a mite since 2018. I'm surprised that you persist in spouting the "pharma is greedy" talking point.

[DewDiligence]

JNJ says its COVID-19 vaccine in development will be distributed at cost (no profit):

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154653491
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154652557

h/t biocqr.

[DewDiligence]

Statement by GILD on Remdesivir donations:

https://www.gilead.com/stories/articles/an-update-on-covid-19-from-our-chairman-and-ceo

Gilead is providing the entirety of this existing supply at no cost, to treat patients with the most severe symptoms of COVID-19. The 1.5 million individual doses are available for compassionate use, expanded access and clinical trials and will be donated for broader distribution following any potential future regulatory authorizations. These doses are for treating patients with severe symptoms, through daily intravenous infusions in a hospital setting. Having a potential treatment in our hands comes with significant responsibility. Providing our existing supplies at no charge is the right thing to do, to facilitate access to patients as quickly as possible and in recognition of the public emergency posed by this pandemic.

[DewDiligence]

GILD’s CEO O’Day on today’s CC: Remdesivir should be different and will be different than GILD’s other products in terms of return on investment. This is unprecedented.

As expected in #msg-154802858.